Kang Yu

1.2k total citations
46 papers, 704 citations indexed

About

Kang Yu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kang Yu has authored 46 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 20 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Kang Yu's work include Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (7 papers) and CAR-T cell therapy research (7 papers). Kang Yu is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (7 papers) and CAR-T cell therapy research (7 papers). Kang Yu collaborates with scholars based in China, United States and Hong Kong. Kang Yu's co-authors include Shenghui Zhang, Songfu Jiang, Yixiang Han, Jianbo Wu, Yongyong Ma, Si Zhang, Yan Zhang, Jianqin Ye, Yan Zhuang and Zhijie Yu and has published in prestigious journals such as Blood, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Kang Yu

44 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang Yu China 17 410 236 166 97 69 46 704
Wenjuan Yu China 15 295 0.7× 107 0.5× 257 1.5× 42 0.4× 49 0.7× 87 618
Maokaı̈ Gong United States 13 349 0.9× 262 1.1× 69 0.4× 53 0.5× 51 0.7× 15 915
Yong Tang China 16 311 0.8× 63 0.3× 86 0.5× 107 1.1× 63 0.9× 32 651
Yun Zhou China 16 367 0.9× 80 0.3× 110 0.7× 84 0.9× 105 1.5× 45 632
Catherine Fady United States 8 378 0.9× 175 0.7× 164 1.0× 53 0.5× 123 1.8× 10 656
Shujuan Huang China 14 315 0.8× 116 0.5× 213 1.3× 99 1.0× 73 1.1× 35 699
Xiaoying Zhao China 13 245 0.6× 86 0.4× 89 0.5× 70 0.7× 58 0.8× 35 501
Wenqin Xiao China 18 625 1.5× 184 0.8× 32 0.2× 274 2.8× 136 2.0× 50 1.1k
J. Todd Williams United States 6 219 0.5× 69 0.3× 70 0.4× 72 0.7× 67 1.0× 7 490
Shailaja Hegde United States 17 338 0.8× 84 0.4× 164 1.0× 112 1.2× 122 1.8× 33 783

Countries citing papers authored by Kang Yu

Since Specialization
Citations

This map shows the geographic impact of Kang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Yu more than expected).

Fields of papers citing papers by Kang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Yu. The network helps show where Kang Yu may publish in the future.

Co-authorship network of co-authors of Kang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kang Yu. A scholar is included among the top collaborators of Kang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Yu. Kang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Yixiang, Rongrong Chen, Cheng Chen, et al.. (2023). MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia. Journal of Translational Medicine. 21(1). 309–309. 3 indexed citations
2.
Zhang, Zhijian, Shujuan Zhou, Kang Yu, et al.. (2023). Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. Frontiers in Immunology. 14. 1146861–1146861. 5 indexed citations
3.
4.
5.
Zhou, Shujuan, et al.. (2019). The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription. Biomedicine & Pharmacotherapy. 119. 109434–109434. 17 indexed citations
6.
7.
Ma, Yongyong, et al.. (2019). NVP-BEZ235-induced autophagy as a potential therapeutic approach for multiple myeloma.. PubMed. 11(1). 87–105. 20 indexed citations
8.
Yu, Kang, et al.. (2019). Comparison of efficacy of HCAG and FLAG re-induction chemotherapy in acute myeloid leukemia patients of low- and intermediate-risk groups. Clinical & Translational Oncology. 21(11). 1543–1550. 4 indexed citations
9.
Sun, Lan, Na Wang, Yi Chen, et al.. (2019). Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen. Biology of Blood and Marrow Transplantation. 25(8). 1592–1596. 16 indexed citations
10.
Zhang, Qianying, et al.. (2019). Plasma fibrinogen levels correlate with prognosis and treatment outcome in patients with non-M3 acute myeloid leukemia. Leukemia & lymphoma. 60(6). 1503–1511. 11 indexed citations
11.
12.
13.
Wang, Na, et al.. (2018). Plasma vascular non-inflammatory molecule 3 is associated with gastrointestinal acute graft-versus-host disease in mice. Journal of Inflammation. 15(1). 1–1. 26 indexed citations
14.
Xing, Chongyun, Bin Liang, Junqing Wu, et al.. (2018). Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia. Cancer Management and Research. Volume 10. 625–635. 3 indexed citations
15.
16.
Zhou, Shujuan, Siqian Wang, Yongyong Ma, et al.. (2016). Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy. Hematology. 21(6). 332–337. 9 indexed citations
17.
Sun, Lan, Jiaqi Li, Junqing Wu, et al.. (2016). MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells. Oncology Reports. 35(6). 3705–3713. 16 indexed citations
18.
19.
Zhang, Shenghui, Yan Zhang, Yan Zhuang, et al.. (2012). Matrine Induces Apoptosis in Human Acute Myeloid Leukemia Cells via the Mitochondrial Pathway and Akt Inactivation. PLoS ONE. 7(10). e46853–e46853. 106 indexed citations
20.
Chen, Junjie, et al.. (2012). Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. Journal of Experimental & Clinical Cancer Research. 31(1). 27–27. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjuan Yu Breakdown of academic impact, for papers by Maokaı̈ Gong Breakdown of academic impact, for papers by Yong Tang Breakdown of academic impact, for papers by Yun Zhou Breakdown of academic impact, for papers by Catherine Fady Breakdown of academic impact, for papers by Shujuan Huang Breakdown of academic impact, for papers by Xiaoying Zhao Breakdown of academic impact, for papers by Wenqin Xiao Breakdown of academic impact, for papers by J. Todd Williams Breakdown of academic impact, for papers by Shailaja Hegde
Rankless by CCL
2026